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Introduction
This year marks 80 years since electro 
convulsive therapy (ECT) was first used 
as a treatment in psychiatry. ECT is an 
emotive subject for service users and 
practitioners alike, with varying opinions 
of its position in current psychiatric 
practice. 
This article examines the origins 
and developmental milestones of ECT, 
explores the literature relating to the 
history of ECT and concludes with our 
own work experiences. 
Before embarking on the history of ECT, 
it is beneficial to start with a description of 
current ECT practice in the UK. We accept 
that we have not captured all the evidence 
in this work.
ECT explained
ECT is a treatment where an electrical 
current is passed briefly through 
electrodes applied to the scalp to induce 
generalised seizure activity.  
The procedure is carried out under 
Historical context
The early 20th century witnessed a major 
revolution in the understanding and 
treatment of mental diseases (Sabbatini, 
1998). New treatments developed for the 
treatment of ‘dementia praecox’, later to 
become known as schizophrenia. 
Treatments were pioneered throughout 
Europe by a number of individuals 
working in psychiatry independent of each 
other’s developments. Sabbatini (1998: 
1) suggests that ‘until then people with 
psychoses were usually locked away in 
asylums, receiving only limited custodial 
care and sometimes social support, with 
practically no effective therapeutic options 
left to the alienist, as psychiatrists were 
called then’.
Other historical treatments
In 1917 Julius Wagner-Jauregg (1857-1940), 
an Austrian professor in psychiatry and 
nervous diseases, introduced malarial 
therapy to treat individuals with ‘general 
paralysis of the insane’ caused by 
advanced neuro-syphillis. Jauregg was the 
first researcher to pursue the link between 
fever and mental diseases, and in 1927 he 
was awarded the Nobel Prize in medicine 
(Sabbatini, 1997/98) 
Manfred Joshua Sakel (1900-1957), 
an Austrian neurophysiologist and 
psychiatrist, introduced insulin coma 
therapy in Vienna in 1927 to treat 
schizophrenia (Stafford-Clark, 1952). 
Egas Moniz (1874-1955), a Portuguese 
neurologist and regarded as the founder 
of psychosurgery, developed the surgical 
procedure prefrontal leucotomy in 1935 
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general anaesthetic in the UK with the 
use of a muscle relaxant. ECT electrodes 
can be placed on both sides of the head 
(bilateral ECT), or on one side of the head 
(right unilateral) (NICE, 2003). In certain 
circumstances, bifrontal may be used 
(Kellner et al, 2010).
ECT should be considered for severe 
depression that is life threatening or 
where a rapid response is required or 
where other treatments have failed 
(NICE, 2009). ECT should not be used 
routinely in moderate depression but 
could be considered if there has been no 
response to multiple drug treatments and 
psychological treatments (NICE, 2009). 
ECT may be considered for treatment of 
a prolonged or severe manic episode and 
in catatonia (NICE, 2003). The consensus 
group for ECT concluded that ECT should 
be considered as a fourth line option for 
patients with schizophrenia for whom 
Clozapine had already been proven 
ineffective or intolerable (Scott, 2005). 
Clinical indications for the use of 
ECT should be based on a thorough 
documented assessment of harms risk 
and potential benefits to the individual. 
These include risks relating to anaesthesia, 
current co-morbidities, anticipated 
adverse events particularly cognitive 
impairment and the risks of not having 
treatment. 
This paper contextualises the history 
and development of ECT. The use of 
language in the paper is from evidence 
of the period cited to encourage reader 
reflection on the use and evidence base 
of ECT.
ECT
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(Gross and Schafer, 2011).  
The late 1920s and early 1930s saw the 
development of ‘convulsive therapy’. Note 
at this point the word ‘electro’ does not 
appear. Convulsive therapy, which was 
thought to be the first effective treatment 
in schizophrenia, was introduced by 
Ladislas J Meduna (1896-1964). Meduna 
was a Hungarian neurologist and 
neuropathologist who studied medicine 
in Budapest from 1914 to 1921. His studies 
were interrupted by military service in the 
Italian front from 1915 to 1918 (Sabbatini, 
1998).
Meduna’s idea of convulsive therapy 
was based on frequent observation 
upon patients with schizophrenia, 
some of whom displayed catatonia, and 
would temporarily lose their psychotic 
symptomatology after spontaneous 
seizures whatever their cause. Such 
spontaneous seizures may occur after 
alcohol withdrawal, infection or head 
injury (Kalinowsky, 1986). 
Colleagues of Meduna, Drs Nyiro and 
Jablonsky in 1929, observed that patients 
with epilepsy who also had psychotic 
features became lucid during periods 
of frequent fitting (McCrae, 2006). 
Nyrio concluded that epilepsy occurred 
less frequently in conjunction with 
schizophrenia than could be accounted for 
by chance alone (Stafford-Clark, 1952). 
Meduna was examining human post 
mortem specimens while working at 
the Hungarian Psychiatric Hospital in 
Budapest in the 1930s. He observed that 
the brains of patients with schizophrenia 
had fewer than the normal number of 
neuroglia (glial cells) and that the brains 
of patients with epilepsy had markedly 
more. Neuroglia are branched cells in the 
central nervous system that provide a 
supporting and communicating network 
for the neurons, the brain cells for thought, 
memory emotion and action (Fink ,1999). 
Meduna postulated that the induction of 
seizures in patients with schizophrenia 
would increase the concentration of glia 
and relieve features of their illness (Fink, 
1999). 
Meduna believed there was a biological 
antagonism between these two diseases 
of the brain (Sabbatini, 2002). This theory 
has not stood the test of time, but Meduna 
proceeded to test its practical implications 
by producing epileptic fits patients with 
schizophrenia (Stafford-Clark, 1952). 
Meduna continued to experiment with 
various substances for their seizure- 
inducing potential in animals, settling 
on intramuscular injections of camphor 
in oil. Meduna injected the substance 
into animals and after 15 to 60 minutes 
produced a grand mal convulsion that 
did not incapacitate or kill the animal. 
The technique he postulated may have 
applications to humans (Fink, 1999).
In the hospital where Meduna worked, 
the belief of many of the doctors was that 
dementia praecox was an inherited genetic 
disorder and as such was not treatable. 
Fearing his work would be criticised, 
Meduna moved his research activities to a 
state hospital for the long-term mentally ill 
at Li-potmezo, near Budapest (Fink, 1999).
Fink (1999) identifies Meduna’s first 
patient was a man called Zolten, who  
aged 33 had been mute, psychotic and 
withdrawn for four years. His diagnosis 
was dementia praecox of the catatonic 
type. On 23 January 1934 Meduna induced 
a seizure in Zolten using camphor. After 
45 minutes Zolten had a classical epileptic 
attack that lasted 60 seconds. Zolten 
recovered without harm and continued 
to have injections of camphor at intervals 
of three to four days. This followed the 
pattern of treatment of malarial therapy 
for neuro syphilis at the time. 
Fink (1999) reported that two days after 
the fifth injection, for the first time in 
four years Zolten got out of bed, began to 
talk, requested breakfast, dressed himself 
without help and retained environmental 
interest. Zolten was surprised when he 
was told he had been in hospital for four 
years. Zolten had three further injections 
and returned home. Meduna treated a 
further five patients with camphor, and 
each of them improved.
Meduna continued to treat patients but 
changed from camphor oil to Metrazol 
(Cardiazol). He found this easier to use, 
the seizure was more immediate and 
predictable. By 1937 Meduna had treated 
110 patients and he reported relief and 
remission of mental illness in 53 of them. 
Convulsive therapy was widely adopted 
at the time, with some suggesting that it 
was far more effective in the treatment 
of depressive illness rather than 
schizophrenia for which it had originally 
targeted. The greatest value seemed to be 
in the treatment of involution melancholia 
that had previously been unresponsive to 
other treatments, which began to respond 
within a matter of days or weeks in the 
most dramatic way (Stafford-Clark, 1952). 
However, there were drawbacks in the 
use of Cardiazol. There was an intense 
dread experienced by patients between 
injection and seizure. Treatment was 
not pleasant causing discomfort as the 
drug began to take effect and patients felt 
physically ill afterwards. The seizures 
were sometimes violent, causing bone 
fractures, joint dislocations and hairline 
fractures to the spinal vertebrae (McCrae, 
2006). Seizures induced by camphor and 
Cardiazol were equally effective, which 
suggested that the therapy was inherent in 
the seizure, not in the mode of induction. 
This conclusion led directly to seizures 
induced by electricity (Fink, 1999).
Development of ECT
ECT was developed by Professor Ugo 
Cerletti and Dr Lucio Bini. Ugo Cerletti 
(1877-1963) was the son of an Italian 
agricultural engineer. He was an Italian 
neurologist and chair of the Department 
of Mental and Neurological Diseases at the 
University of Rome in 1935. (Sabbantini, 
1997/98). Lucio Bini (1908-1964) was an 
Italian psychiatrist and Professor at the 
University of Rome in 1935. 
As a neurologist Cerletti was particularly 
interested in the study of epilepsy. He 
carried out experiments on animals, 
especially dogs, repeatedly inducing 
epileptic seizures using an electric current 
of 125 volts. During this experimentation, 
he became aware of convulsive therapy 
for schizophrenia and began treatment-
using Cardiazol. 
He theorised on the possibilities of 
using ‘electroshock’, as he called it, on 
humans (Bollorino et al, 2012). Cerletti 
visited a Rome abattoir where pigs were 
slaughtered. Before slaughter the pigs 
were electrocuted using a large pair of 
ECT
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pincers held on their heads. Electricity 
of 70 to 80 volts was delivered through 
the pincers, causing the pig to become 
unconscious and have a generalised 
convulsion. 
Cerletti then began to conduct his 
own experiments using dogs, passing an 
electrical current of 125 volts (alternating 
current) through the head for a fraction 
of a second causing a seizure. Reportedly 
this activity did not cause any significant 
problems or endanger life. He theorised 
that applying an electrical current in a 
similar way in humans without much 
danger could be effective (Bollorino et al, 
2012).
First clinical use of ECT
Under Celettis’ instruction Bini built a 
machine to deliver brief electric shocks to 
humans. It became known as the Bini-
Cerletti electro shock apparatus (Aruta, 
2011). The following case study was 
reported as an early example of efficacy: 
A man in his 40s was found wandering 
at a railway station from one train to 
another without a ticket. He was acting 
in a strange way, answering questions 
in a strange language which was 
incomprehensible. He was admitted to 
hospital suffering from hallucinations and 
delirious ideas about being under some 
kind of influence. Apart from that he was 
lucid and well orientated, but apathetic 
and lacking in willpower. On the ward he 
was reported as always lying contentedly 
on his bed murmuring, and was diagnosed 
as having schizophrenia (Bollorino et al, 
2012). It was reported that a few years 
earlier he had responded to treatment 
with Cardiazol in the Medical Academy of 
Rome (Fink 1999). 
In April 1938 the first ‘electroshock’, 
as it was then called, was delivered. 
Having fixed two electrodes soaked in 
a saline solution with an elastic band 
to the frontal parietal area, 80 volts of 
electricity was delivered for one-fifth of 
a second. Following an initial stiffening 
of his muscles the patient fell back onto 
the bed without losing consciousness. 
A further electroshock of 110 volts was 
given for one-fifth of a second. The patient 
immediately had a very brief general 
spasm and epileptic seizure. The seizure 
went on for some time, with the patient 
gradually regaining consciousness. The 
patient then woke up and smiled. When 
asked what had happened to him he 
thought he may have been sleeping. He 
went on to have 11 electroshocks and had 
a complete remission of his symptoms and 
was discharged in June 1938 (Bollorinio et 
al, 2012). 
 After 10 to 20 treatments on alternate 
days the improvement in most of 
the patients was startling. One of the 
unexpected treatment benefits was that it 
provoked retrograde amnesia, or memory 
loss of events immediately anterior to the 
shock. Patients had no negative feelings 
towards the treatment (as had happened 
with Metrazol), and was considered to be 
reliable, controllable and less dangerous 
to the patient than Metrazol (Sabbatini, 
1998). It is noteworthy that these are single 
case report examples and form lower 
hierarchal levels of research evidence. 
Use of ECT in the UK
ECT was introduced to the UK in 1939 by 
Lothar Kalinowsky, a colleague of Cerlettis. 
He demonstrated ECT at the Burden 
Neurological Institute and published in 
The Lancet in December 1939 (Kalinowsky, 
1939). Also in 1939 and independently of 
Kalinowsky, Edward Golla, the director 
of the Burdon Neurological Institute in 
Bristol, and his assistant Grey Walter 
commissioned a company Edison Swan 
Electric to build an ECT machine. They 
treated five psychotic patients from 
Barnwood House Hospital in Gloucester 
(Shorter, 2016). They also published in The 
Lancet in December 1939.
ECT soon became more popular than 
Cardiazol treatment in mental hospitals in 
the UK (McCrae, 2006). Brain and Strauss 
(1945) suggested that ECT was especially 
useful in the treatment of affective 
psychosis and the therapeutic value in 
schizophrenia was reported as limited. 
Some psychiatrists thought that ECT 
should be restricted to depression (Allen, 
1949). Hemphill and Grey Walter (1941) 
report results following ECT for patients 
for patients with schizophrenia, mania, 
depression and involutional melancholia. 
It was also used in treatment of people 
who had suffered war neurosis and 
admitted to neurosis centres or mental 
hospitals with severe depression (Sargent, 
1942). Views on ECT were generally 
positive in the early years of its use. Most 
patients received treatment 2-3 times 
a week or occasionally daily (Hemphill 
and Walter, 1941). Some psychiatrists 
experimented with more intensive 
treatment regimens. One of these 
psychiatrists was Robert Russell, who later 
formed a company called Ectron Ltd to 
manufacture ECT machines (Easton 2010). 
These machines were used extensively in 
the UK (Pippard, 1992). 
Modified and unmodified ECT
ECT was given without the use of muscle 
relaxant or anaesthesia until the early 
1950s (termed ‘unmodified ECT’). 
Psychiatrists in the 1940s experimented 
with curarae to try to modify convulsions 
that were sometimes so intense they 
caused long bone fractures or dislocations. 
By 1951 succinylcholine was being used 
as an alternative to curarae, which was 
deemed safer. In addition, a short-acting 
anaesthetic administered to prevent the 
terrifying feelings of not being able to 
breathe, with the muscle relaxants known 
as ‘modified ECT’ (Kiloh et al, 1988). By 
1957 some hospitals in the UK were still 
not using modified ECT. 
A patient named Bolam received ECT 
at Friern Hospital London unmodified. 
Bolam sustained bilateral hip fractures 
and he sued the hospital (Bolam v Friern 
Hospital Management Committee, 1957). 
Bolam was a voluntary patient at a 
psychiatric unit. He agreed to undergo 
ECT, was not given any muscle relaxant, 
and was not restrained during the 
procedure. He flailed violently during the 
procedure, and suffered serious injuries. 
He sued the hospital for compensation. He 
argued it had been negligent by not giving 
muscle relaxants, not restraining him and 
crucially not warning him about the risks 
involved. It was common medical practice 
at the time not to warn patients of the risks 
unless they asked. This was a landmark 
ruling for medical negligence claims. 
The case caused great debate about ECT 
ECT
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practice and by the early 1960s all patients 
were receiving a general anaesthetic 
and muscle relaxant (Easton, 2010). 
Bolam reasonableness has however been 
revised in the Supreme Court decision of 
Montgomery v Lanarkshire Health Board 
(2015). Readers may also consider the 
case of Bolitho regarding medical risks 
and benefits that are a matter of clinical 
judgement and decisions made should 
withstand logical analysis (Bolitho v City 
and Hackney Health Authority, 1996). The 
Bolam and Bolitho cases still stand but can 
be challenged, if it can be satisfied that the 
body of expert medical opinion cannot be 
logically supported.
Unilateral ECT
Bilateral ECT was the most common form 
of electrode placement in ECT. However, 
in a paper delivered to a quarterly 
meeting of the Royal Medico-Psychological 
Association at Bristol in May 1957, 
psychiatrists Lancaster, Steinert and Frost, 
who were working in Bristol and Chester, 
explained the technique of ‘unilateral ECT’. 
This was in relation to memory loss that 
was a major side-effect of bilateral ECT. 
They concluded that unilateral ECT 
was of use in elderly patients with severe 
arteriosclerosis who were depressed and 
had nutritional difficulties. Patients with 
superior intelligence, young patients 
(under the age of 40) or presented with 
predominantly neurotic features and 
depressed sufficiently may warrant ECT 
(Lancaster et al, 1958). Unilateral ECT is 
still used as a method of delivering ECT in 
current practice, although the parameters 
mentioned above have changed 
somewhat. ECT continued to be used as a 
treatment in psychiatry in the 1960s and 
1970s. 
Perrin et al (2012) suggest that although 
ECT has been practised for over 70 
years the underlying mechanisms of 
action remain unclear. A study was 
undertaken in a group of nine patients 
where MRI scans were used along with a 
unique data-driven analysis approach to 
examine functional connectivity within 
the brain before and after ECT. The 
findings reported added weight to the 
emerging hyper connectivity hypothesis 
in depression and supported the proposal 
that increased connectivity may constitute 
both a biomarker for mood disorder and a 
potential therapeutic target.
Reflections on practice and 
standards
My first memories of witnessing ECT were 
in the early 1970s (writes Colin Jones). ECT 
was administered on a ward, which was of 
the Nightingale style. Patients would lie on 
the top of the beds with their heads facing 
into the middle of the ward, and the beds 
would be screened. About half an hour 
before treatment subcutaneous atropine 
would be given. My memory is that the 
patient considered this to be the worst 
part of the whole ECT treatment. Atropine 
was administered to dry up secretions 
(no longer used in this regard) and was 
likened to a bee sting. 
The ECT team, consisting of a 
psychiatrist, an anaesthetist and nurses, 
would then start at the top of the ward 
and treat patients in turn. Brietal 
(Methohexitone) was the anaesthetic 
of choice and Brevidil-E (Suxethonium 
chloride) the muscle relaxant. The ECT 
machine in use was the Ectron. The 
patient was placed in the recovery position 
following treatment and allowed to wake 
naturally. Physical observations including 
temperature, pulse, respirations and blood 
pressure were taken at intervals. When 
able the patients were escorted to the day 
area of the ward and offered refreshments 
before returning to their respective wards. 
In 1978 I moved to a purpose-built newly 
commissioned psychiatric unit. Within it 
was a dedicated ECT suite with a waiting 
area, pre- treatment room, treatment room 
and a 12-bed recovery area.
Concerns were expressed by clinicians 
and the general public relating to various 
aspects of ECT. In 1977 The Royal College 
of Psychiatrists issued a memorandum 
on the use of ECT. It dealt with three key 
areas: a review of the scientific evidence 
of the effectiveness of ECT and of any 
adverse effects, recommendations about 
the standards to be observed in the 
administration of ECT, and the medico-
legal problems of giving this treatment.
(Royal College of Psychiatrists, 1977)
Following this report a survey of ECT 
practice in Britain was carried out for the 
Royal College of Psychiatrists (Pippard 
and Ellam, 1981). A questionnaire was 
sent to all members of the college, to all 
consultants in psychiatry and to all doctors 
in training. A 95% response rate was 
achieved. 
A question was asked regarding the 
college’s memorandum on ECT in 1977. 
Some 91% of respondents thought it had 
given inadequate guidance on how to 
give ECT. Respondents were critical of the 
insufficient detail provided, said there was 
not enough importance placed on staff 
training, and cited inadequate information 
on consent procedures. 
Another questionnaire on how ECT 
was given was sent to 347 ECT clinics 
(90% of the total clinics operational). 
Visits were made to 180 of these and ECT 
was observed in 101 of them. The survey 
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sought doctors’ opinions, how ECT was 
given, consent and responsibility, the 
type of ECT machine used, anaesthesia, 
staff, techniques of administration, 
and description of clinics. The 
recommendations included:
• Guidance on the way ECT should be 
administered.
• One consultant psychiatrist should 
take full responsibility for the ECT clinic, 
teaching and training.
• The physical conditions under which ECT 
is given should be reviewed.
• Guidance on the machines used. 
• Advice on clinical decisions. 
A further survey was conducted by 
Pippard in 1991, which was restricted to 
the North East Thames and East Anglian 
regions. This included 35 NHS hospitals 
and five private clinics. He reported 
that since 1981 there had been much 
improvement in the physical conditions 
where ECT was given and in anaesthetic 
practice. Nursing was good or excellent in 
the majority of clinics (Pippard 1991).
Development of practice 
standards
The National Association of Lead Nurses 
in ECT (NALNECT) was formed in 2002. 
This group of nurses working in ECT 
represented nurses working across ECT 
departments within England, Northern 
Ireland and Wales (the Scottish equivalent 
is the Scottish ECT Accreditation Network 
(SEAN)) The aims of NALNECT are to:
• Provide expert knowledge, information 
and advice on all matters relating to ECT 
practice.
• Provide a forum for the provision of 
evidence-based practice.
• Promote the provision of special interest 
groups and to enable every ECT clinic to 
be represented. The special interest groups 
run regionally throughout the country.
• To work collaboratively with the ECT 
Accreditation Service (ECTAS).
• To facilitate and promote ECT nurse 
education.
• Network with the Royal College of 
Nursing, Royal College of Psychiatrists, 
the Scottish Audit Network and other 
appropriate national bodies.
ECTAS was established in 2003 to 
promote better standards of practice 
in ECT services in England, Wales, 
Northern Ireland and the Republic of 
Ireland. ECTAS is managed by the Royal 
College of Psychiatrists’ centre for Quality 
Improvement and works in partnership 
with the Royal College of Anaesthetists, 
the Royal College of Nursing and service 
users. The best available evidence 
informs the ECTAS model standards to 
encourage clinics to improve continuously 
(ECTAS, 2018). Readers are encouraged 
to visit www.rcpsych.ac.uk/quality/
qualityandaccreditation/ectclinics/ectas/
ectasstandards.aspx.
Nurse-administered ECT
Nurse-administered ECT is a more recent 
development. ECT has traditionally 
been administered by medical staff 
assisted by nurses. During a global 
telephone conference with participants 
from Canada, the US, New Zealand and 
Australia in January 2012 the concept of 
nurse-administered ECT was discussed. 
This evoked lively discussion in the UK 
and globally. The issue was raised at the 
special committee of the Royal College of 
Psychiatrists, which then gave permission 
for four pilot sites in the UK. 
Since then nurse-administered ECT has 
been agreed by the Nursing and Midwifery 
Council, the Royal College of Psychiatrists 
and individual NHS trusts. The Royal 
College of Nursing does not have a specific 
view on nurse administered ECT, but does 
support advance nursing practice (Leyden 
and Cornish, 2015).
Conclusion
This paper has sought to outline the 
history and development of ECT to 
encourage the reader to reflect on mental 
health practice. We accept this may evoke 
different feelings from the mental health 
workforce, and as nurses we should 
always question the evidence base to 
inform our practice. Patients must be at 
the centre of decision making and deserve 
the best possible evidence.  
Although ECT use was initially 
developed from single patient case study 
designs, recently there have been random 
controlled trials that offer higher forms 
of evidence, which robustly support the 
efficacy of ECT. This is particularly in 
patients who are severely ill and this can 
be life-saving (Kerner and Prudic, 2014). 
The development of relatively recent 
national standards is welcome and ensures 
that the practice of ECT is consistent 
across different centres with measurable 
outcomes. n
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